SAN FRANCISCO, May 25, 2022 – Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced survey findings revealing that seasonal allergies impact job performance, commuting, and the ability to enjoy outdoor activities. A randomized survey of 2,000 U.S. allergy sufferers* was conducted last month by […]
77% year-over-year growth in unit sales direct-to-consumer; 219% increase in gross profit. SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the quarter ended March 31, 2022. “I am pleased that our strategy to grow direct-to-consumer sales […]
SAN FRANCISCO, CA – May 9, 2022 – Jennifer Ernst, CEO of Tivic Health® Systems, Inc. (Nasdaq: TIVC), is an invited speaker at FORTUNE Brainstorm Health and will participate on the panel Driving Digital Health: Where Wearables Are Headed Next. The session will take place on May 11 and panelists will include Robert Ford, chairman […]
SAN FRANCISCO, April 14, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”) a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that financial results for the fourth quarter of 2021 and the year-end shareholder update will take place via conference call on Tuesday, April 19, 2022, […]
Veronica Cai Appointed to Chief Financial Officer; Ryan Sabia Promoted to Chief Operating Officer and Sanjay Ahuja Joined as Senior Vice President, Quality Assurance & Regulatory Affairs SAN FRANCISCO, April 5, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC) (“Tivic Health” or the “Company”), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, […]
SAN FRANCISCO, February 7, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced that ClearUP® Sinus Pain Relief was named Best Sinus Pain Relief Solution of 2021 by Global Health & Pharma Magazine (GHP). The GHP Technology Awards celebrate businesses and professionals who have made exceptional […]
Growing recognition of Bioelectronic Medicine as an important new therapeutic category SAN FRANCISCO, January 31, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, was one of two companies featured in the ABC News story “New Bioelectronic Technologies Could Signal the Future of Medicine.” Will Carr reported on […]
60-person clinical trial to investigate therapeutic device as an alternative to opioids following sinus surgeries SAN FRANCISCO, January 19, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced initiation of its second clinical study investigating the extension of the company’s bioelectronic platform, offering a potentially new […]
SAN FRANCISCO, December 20, 2021 – Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, names Mindgruve, a modern marketing agency, as its digital marketing agency of record. Mindgruve will work with Tivic Health to develop an integrated marketing and brand strategy that supports marketing and sales efforts in […]
SAN FRANCISCO, December 8, 2021 – Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, has been named to Fast Company’s inaugural Next Big Things in Tech 2021 honoring the technology breakthroughs that promise to shape the future of their industries—from healthcare to agriculture to artificial intelligence and more. […]
Join the Tivic Health Family!
Get access to exclusive discounts, product info, and more!
